AT356303B - Verfahren zur herstellung von 9,11-halo- genierten steroiden - Google Patents

Verfahren zur herstellung von 9,11-halo- genierten steroiden

Info

Publication number
AT356303B
AT356303B AT663077A AT663077A AT356303B AT 356303 B AT356303 B AT 356303B AT 663077 A AT663077 A AT 663077A AT 663077 A AT663077 A AT 663077A AT 356303 B AT356303 B AT 356303B
Authority
AT
Austria
Prior art keywords
steroids
halo
producing
generated
generated steroids
Prior art date
Application number
AT663077A
Other languages
English (en)
Other versions
ATA663077A (de
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ATA663077A publication Critical patent/ATA663077A/de
Application granted granted Critical
Publication of AT356303B publication Critical patent/AT356303B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT663077A 1976-09-16 1977-09-15 Verfahren zur herstellung von 9,11-halo- genierten steroiden AT356303B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75809A LU75809A1 (de) 1976-09-16 1976-09-16

Publications (2)

Publication Number Publication Date
ATA663077A ATA663077A (de) 1979-09-15
AT356303B true AT356303B (de) 1980-04-25

Family

ID=19728351

Family Applications (1)

Application Number Title Priority Date Filing Date
AT663077A AT356303B (de) 1976-09-16 1977-09-15 Verfahren zur herstellung von 9,11-halo- genierten steroiden

Country Status (13)

Country Link
JP (1) JPS5337652A (de)
AT (1) AT356303B (de)
AU (1) AU514425B2 (de)
BE (1) BE858709A (de)
CA (1) CA1105003A (de)
DE (1) DE2741067A1 (de)
DK (1) DK410077A (de)
FR (1) FR2364928A1 (de)
GB (1) GB1584826A (de)
LU (1) LU75809A1 (de)
NL (1) NL7710086A (de)
SE (1) SE7710337L (de)
ZA (1) ZA775537B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3069074D1 (en) 1979-11-16 1984-10-04 Sterosynt Ltd 6-alpha-9-alpha-difluoro-16-beta-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
IT1209140B (it) * 1979-11-16 1989-07-10 Prochem Ets 6 alfa-fluoro-prednisolone 17,21-diesteri.

Also Published As

Publication number Publication date
DK410077A (da) 1978-03-17
GB1584826A (en) 1981-02-18
DE2741067A1 (de) 1978-03-23
SE7710337L (sv) 1978-03-17
JPS5337652A (en) 1978-04-06
LU75809A1 (de) 1978-05-12
CA1105003A (en) 1981-07-14
NL7710086A (nl) 1978-03-20
ZA775537B (en) 1978-07-26
AU514425B2 (en) 1981-02-12
FR2364928B1 (de) 1981-03-06
FR2364928A1 (fr) 1978-04-14
AU2884877A (en) 1979-03-22
BE858709A (fr) 1978-03-15
ATA663077A (de) 1979-09-15

Similar Documents

Publication Publication Date Title
ATA196177A (de) Verfahren zur herstellung von chlordioxid
AT353251B (de) Verfahren zur herstellung von m- phenoxybenzaldehyd
AT351508B (de) Verfahren zur herstellung von 2,5-dichlorphenol
AT358729B (de) Verfahren zur herstellung von 3-halogenmethyl-3 -cephemen
AT359990B (de) Verfahren zur herstellung von 1,3-dihydroxy-2- -aminopropan
AT347437B (de) Verfahren zur herstellung von benzoylcyanid
AT352138B (de) Verfahren zur herstellung von 2-chlorsulfinyl- azetidin-4-onen
AT347439B (de) Verfahren zur herstellung von benzoylcyanid
AT360507B (de) Verfahren zur herstellung von 2,4,5-trichlor- phenol
ATA151279A (de) Verfahren zur herstellung von neuen mehrfach halogenierten steroiden
AT364817B (de) Verfahren zur herstellung von aminocyclolen
AT356129B (de) Verfahren zur herstellung von substituierten 1-carbamoyl-2-cyanaziridinen
AT345780B (de) Verfahren zur herstellung von neuem 3,7- dimethyl-3-hydroxyoctannitril
AT347438B (de) Verfahren zur herstellung von benzoylcyanid
AT356815B (de) Verfahren zur herstellung von 3',4'-dideoxy- kanamycin b
DD134228A5 (de) Verfahren zur herstellung von spirooxazolidindionen
AT353268B (de) Verfahren zur herstellung von 6a,10a-cis- hexahydrodibenzopyranonen
AT355013B (de) Verfahren zur herstellung von 2-oxo-pyrrolidin- n-alkylamiden
AT358055B (de) Verfahren zur herstellung von 2-chlor-4,6-bis- -alkylamino-s-triazinen
AT374809B (de) Verfahren zur herstellung von alkalizellulose
AT356303B (de) Verfahren zur herstellung von 9,11-halo- genierten steroiden
AT353759B (de) Verfahren zur herstellung von 1,2-dichloraethan
AT359476B (de) Verfahren zur herstellung von 2,3-dichlor-1-(c1 -7)-alkoxybenzol
AT364840B (de) Verfahren zur herstellung von 1,3-dimethyl-2-methylimino-4-imidazolidinonderivaten
ATA568178A (de) Verfahren zur herstellung von 2,4-diamino-5- -benzylpyrimidinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee